2012
DOI: 10.1136/jnnp-2012-303524.11
|View full text |Cite
|
Sign up to set email alerts
|

A11 Induced pluripotent stem cells for basic and translational research on HD

Abstract: BackgroundThe expression of mutant HTT leads to many cellular alterations, including abnormal vesicle recycling, loss of signalling by brain-derived neurotrophic factor, excitotoxicity, perturbation of Ca2+ signalling, decreases in intracellular ATP, alterations of gene transcription, inhibition of protein clearance pathways, mitochondrial and metabolic disturbances, and ultimately cell death. While robust mammalian systems have been developed to model disease and extensive mechanistic insights have emerged, s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Since the discovery that adult human somatic cells can be reprogrammed into induced pluripotent stem cells (iPSC) by overexpression of only four transcription factors (Takahashi et al, 2007), a new era of research has started. Recently, numerous studies using iPSC-derived neurons have been published, including iPSC-derived neurons to model neurodegenerative diseases (Israel et al, 2012;Mattis et al, 2012;Kaye and Finkbeiner, 2013;Ryan et al, 2013;Richard and Maragakis, 2014). These proof-of principle studies recapitulate the key aspects of the different pathologies, including aberrant synaptic abnormalities and functional deficits (Penzes et al, 2011;Hick et al, 2014;Wen et al, 2014).…”
Section: Introductionmentioning
confidence: 97%
“…Since the discovery that adult human somatic cells can be reprogrammed into induced pluripotent stem cells (iPSC) by overexpression of only four transcription factors (Takahashi et al, 2007), a new era of research has started. Recently, numerous studies using iPSC-derived neurons have been published, including iPSC-derived neurons to model neurodegenerative diseases (Israel et al, 2012;Mattis et al, 2012;Kaye and Finkbeiner, 2013;Ryan et al, 2013;Richard and Maragakis, 2014). These proof-of principle studies recapitulate the key aspects of the different pathologies, including aberrant synaptic abnormalities and functional deficits (Penzes et al, 2011;Hick et al, 2014;Wen et al, 2014).…”
Section: Introductionmentioning
confidence: 97%